BSEInsider Trading / SAST15 Sept 2026 · 15 Sept 2026, 04:45 pm

Please find the enclosed intimation of the Company as per the captioned subject for your reference.

AstraZeneca Pharma India Ltd · 506820

✦ AI Summary

AstraZeneca Pharma India Ltd has announced the closure of its trading window from September 16, 2026, until 48 hours after the declaration of its un-audited financial results for the quarter and half year ending September 30, 2026.

Analysis Scores

Earnings Impact0/10

Growth Catalyst0/10

Governance Concern0/10

Regulatory Risk0/10

Balance Sheet Risk0/10

Liquidity Impact0/10

Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

Full Announcement

AstraZeneca Pharma India Ltd - 506820 - Closure of Trading Window

Attachments (1)

📄

752ec087-e282-470d-89a2-dbf27485f009.pdf

pdf

Download →

View document text

September 15, 2026 The Manager - Listing National Stock Exchange of India Ltd. Exchange Plaza, Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051 The Manager - Listing BSE Limited P J Towers, Dalal Street, Fort, Mumbai – 400 001 Dear Sir/ Madam, Sub: Closure of Trading Window This is to inform you that, in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, read with AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading, the Trading Window for dealing in the Equity Shares of the Company will be closed from September 16, 2026 and the same shall reopen after 48 hours from the declaration of Un-audited Financial Results of the Company for the quarter and half year ending September 30, 2026. We request you to please take the same on record. Thanking you, For AstraZeneca Pharma India Limited Tanya Sanish Company Secretary & Compliance Officer